Update history: LCD and article updates
View the most recent updates for our LCDs and articles. A final LCD has become effective.
Articles
Article Type
Category
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration...
Avoid negative impacts to your claims -- review billing and coding article A58918 molecular pathology and genetic testing
View this important information you must know if you bill for molecular pathology and genetic testing. This article was updated...
Reporting the national drug code
Read this article for helpful information to report the national drug code on claims.
Prior authorization for ambulance transports is for repetitive transports
A repetitive service is defined as medically necessary ambulance transportation that is furnished three or more times during a...
Drugs and biologicals: Self-administered drug exclusions
Self-administered drugs
Self-Administered Drug Exclusion List (A52571) (Currently in effect)
‘Reasonable and necessary’ guidelines
View these guidelines regarding what it means for a service to be "reasonable and necessary."
Open meeting fact sheet
The purpose of the open meeting is to allow interested parties the opportunity to make presentations of information and offer...
SPRAVATO® (esketamine) nasal spray CIII place of service (POS) requirements
View our latest article on SPRAVATO® (esketamine) nasal spray - used to treat treatment-resistant depression in adults - and its...
Humanitarian device exemption
First Coast may consider coverage of a humanitarian use device, intended to benefit a small patient population, when the...